Scholarlink

<p>Gaseous micro-emboli (GME) represent a persistent risk in extracorporeal circulation systems, such as extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass (CPB). These emboli can lead to severe complications, including neurological damage and organ dysfunction, underscoring the urgent need for innovative solutions to mitigate this risk. This study introduces and evaluates a novel device: a polyvinyl chloride (PVC) arterial line equipped with a gas extraction membrane and a hypobaric oxygen flow system. The arterial line features an external oxygen flow maintained at hypobaric pressure (&lt; 680&#xa0;mmHg), separated from the blood flow by a semi-permeable silicone membrane. This configuration enables the selective removal of gaseous emboli from the bloodstream, transferring them into the hypobaric oxygen flow and thereby significantly reducing the embolic load. Initial literature and theoretical models demonstrate the effectiveness of this hypobaric technique in reducing gaseous micro-emboli, highlighting its potential to improve safety in ECMO and CPB applications. The purpose of this article is to introduce this innovative arterial line and explore its clinical potential for enhancing patient safety and outcomes. Compared to traditional filtration methods, the device offers significant advantages, including greater efficiency in GME removal, reduced hemodynamic resistance, and compatibility with low-anticoagulation settings. This study lays the groundwork for future research and development, with the potential to advance extracorporeal circulation technology and transform the standard of care in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Arterial Line with Gas Extraction Membrane and Hypobaric Oxygen Flow: A Novel Approach to Gaseous Micro-emboli Elimination in Extracorporeal Circulation

  • 期刊论文

  • 发表日期：

    2025年1月10日

查看全文
  • Ignazio Condello

摘要

Gaseous micro-emboli (GME) represent a persistent risk in extracorporeal circulation systems, such as extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass (CPB). These emboli can lead to severe complications, including neurological damage and organ dysfunction, underscoring the urgent need for innovative solutions to mitigate this risk. This study introduces and evaluates a novel device: a polyvinyl chloride (PVC) arterial line equipped with a gas extraction membrane and a hypobaric oxygen flow system. The arterial line features an external oxygen flow maintained at hypobaric pressure (< 680 mmHg), separated from the blood flow by a semi-permeable silicone membrane. This configuration enables the selective removal of gaseous emboli from the bloodstream, transferring them into the hypobaric oxygen flow and thereby significantly reducing the embolic load. Initial literature and theoretical models demonstrate the effectiveness of this hypobaric technique in reducing gaseous micro-emboli, highlighting its potential to improve safety in ECMO and CPB applications. The purpose of this article is to introduce this innovative arterial line and explore its clinical potential for enhancing patient safety and outcomes. Compared to traditional filtration methods, the device offers significant advantages, including greater efficiency in GME removal, reduced hemodynamic resistance, and compatibility with low-anticoagulation settings. This study lays the groundwork for future research and development, with the potential to advance extracorporeal circulation technology and transform the standard of care in clinical practice.